Uncategorized

We are hiring!

Se buscan candidatos/as interesados en desarrollar su carrera científica en la empresa Inhibitec Anticuerpos S.L., para cubrir un puesto de doctor. Inhibitec-Anticuerpos S.L. es una start-up creada en el año 2019 en Santander que está desarrollando nuevas terapias para el tratamiento de enfermedades inflamatorias crónicas, en especial la artritis psoriásica mediante el desarrollo de un …

We are hiring! Read More »

BIOSPAIN Congress (26-28th September 2023)

Inhibitec’ s team had the privilege to participate in BIOSPAIN 2023, one of the main international biotechnology events in southern Europe, held in Barcelona. This was a dynamic conference marked by numerous meetings we had which offered the great opportunity to share our innovative therapy for Psoriatic Arthritis with potential investors and collaborators. This platform …

BIOSPAIN Congress (26-28th September 2023) Read More »

Inhibitec Anticuerpos is selected by the NEOTEC 2021 Grant (SNEO- 2021 1187). ‘CDTI Supported/ Subvencionado por CDTI’

We are thrilled to announce that Inhibitec has been selected as a recipient of the NEOTEC 2021 grant provided by CDTI (Center for Industrial Technological Development). This prestigious grant is designed to support the initiation of new entrepreneurial projects that leverage technology or knowledge developed from research activities, with a business strategy focused on technology …

Inhibitec Anticuerpos is selected by the NEOTEC 2021 Grant (SNEO- 2021 1187). ‘CDTI Supported/ Subvencionado por CDTI’ Read More »

Inhibitec Antibodies, S.L. Cantabrian biotechnology company

Inhibitec Antibodies, S.L. Cantabrian biotechnology company, spin-off of the CSIC and University of Cantabria, has developed a monoclonal antibody for a new therapeutic target. Last week,  it was in Cambridge, within the Idea Spark Program designed by MIT and SODERCAN.  A significant number of psoriatic patients with severe disease do not respond to existing therapies. …

Inhibitec Antibodies, S.L. Cantabrian biotechnology company Read More »

Scroll to Top